2.23

2.62% -0.06

After Hours: 2.33 0.10 +4.48%

Stereotaxis Inc (STXS)

Overview News Price History Option Chain Discussions Forecast Stock Split

Stereotaxis Inc stock is traded at $2.23, with a volume of 177.07K. It is down -2.62% in the last 24 hours and up +17.99% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.

Previous Close:

$2.29

Open:

$2.3

24h Volume:

177.07K

Relative Volume:

0.71

Market Cap:

$192.76M

Revenue:

$25.14M

Net Income/Loss:

$-21.57M

P/E Ratio:

-8.2593

EPS:

-0.27

Net Cash Flow:

$-12.23M

1W Performance:

+9.85%

1M Performance:

+17.99%

6M Performance:

+12.63%

1Y Performance:

+31.95%

1-Day Range:

$2.22

$2.30

1-Week Range:

$2.02

$2.30

52-Week Range:

$1.56

$3.29

Stereotaxis Inc Stock (STXS) Company Profile

Name

Stereotaxis Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

314-678-6100

Address

4320 Forest Park Avenue, Suite 100, St. Louis, MO

Employee

118

Twitter

@stereotaxis

Next Earnings Date

2024-11-11

Latest SEC Filings

STXS's Discussions on Twitter

Compare STXS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
STXS Stereotaxis Inc	2.23	192.76M	25.14M	-21.57M	-12.23M	-0.27
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-24	Initiated	ROTH MKM	Buy
Jul-12-22	Initiated	Aegis Capital	Buy
Jun-23-22	Initiated	B. Riley Securities	Buy
Jan-05-22	Initiated	Craig Hallum	Buy
Jan-05-22	Initiated	Loop Capital	Buy
May-26-21	Initiated	Piper Sandler	Overweight
Sep-08-20	Initiated	Northland Capital	Outperform
Apr-09-20	Initiated	Cowen	Outperform
Apr-07-20	Initiated	Lake Street	Buy

View All

Stereotaxis Inc Stock (STXS) Latest News

Nov 27, 2024

Stereotaxis surgical robot gets regulatory nod in China - Robot Report

Nov 27, 2024

Nov 26, 2024

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 26, 2024

Pre-Market Momentum For Stereotaxis (STXS) Following Key Approval - Stocks Telegraph

Nov 26, 2024

Nov 25, 2024

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China - GlobeNewswire

Nov 25, 2024

Stereotaxis Secures China NMPA Approval for Genesis Robotic Surgery System | STXS Stock News - StockTitan

Nov 25, 2024

Nov 20, 2024

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System - GlobeNewswire

Nov 20, 2024

Stereotaxis Genesis Robotic System Debuts at Portugal's Leading Cardiac Center | STXS Stock News - StockTitan

Nov 20, 2024

Nov 15, 2024

Stereotaxis earnings missed by $0.03, revenue topped estimates - Investing.com UK

Nov 11, 2024

Stereotaxis Q3 Revenue Surges 18% as GenesisX Robotic System Gains CE Mark | STXS Stock News - StockTitan

Nov 11, 2024

Kansas hospital begins robotic heart program with Stereotaxis surgical robot - Robot Report

Nov 11, 2024

Robotic Catheter Systems Market Expected to See Prominent - openPR

Nov 11, 2024

Nov 08, 2024